OI prophylaxis in antiretroviral responders: stay the course or bite the bullet?
Currier
J S
JS
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007156:Immunologic Memory; D008213:Lymphocyte Activation; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000517:prevention & control*; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000276:immunology; D019562:Viral Load
D019380:Anti-HIV Agents